je.st
news
Tag: idenix
Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech
2014-12-01 14:52:54| Biotech - Topix.net
The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.
Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech
2014-12-01 14:52:53| Biotech - Topix.net
The CEO who sold Idenix Pharmaceuticals to Merck & Co . in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.
Merck Completes Tender Offer to Acquire Idenix
2014-08-05 12:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) at a purchase price of $24.50 per share. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: offer
acquire
tender
completes
Merck starting tender offer for Idenix
2014-06-20 17:00:20| Biotech - Topix.net
Merck is starting a tender offer on Friday to buy all of the outstanding shares of hepatitis C treatment maker Idenix Pharmaceuticals Inc. Merck & Co.
Tags: offer
starting
tender
merck
Merck Begins Tender Offer to Acquire Idenix
2014-06-20 13:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX). On June 09, 2014, Merck announced its intent to acquire Idenix. Language: English Contact: Media:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: offer
begins
acquire
tender